<i>TSC2</i> Loss in Lymphangioleiomyomatosis Cells Correlated with Expression of CD44v6, a Molecular Determinant of Metastasis
Gustavo Pacheco–Rodriguez(National Institutes of Health), Joel Moss(National Institutes of Health), Jianwu Wang(South China Agricultural University), Wendy K. Steagall(National Heart Lung and Blood Institute), Thomas N. Darling(National Institutes of Health), Hiroshi Hashimoto(National Heart Lung and Blood Institute), Denise Crooks(National Institutes of Health), Shaowei Li(Uniformed Services University of the Health Sciences), Linda A. Stevens(National Heart Lung and Blood Institute)
Cited by 61
Related Papers
Efficacy and Safety of Sirolimus in Lymphangioleiomyomatosis
|New England Journal of Medicine|2011|1.1k
The NHLBI Lymphangioleiomyomatosis Registry
|American Journal of Respiratory and Critical Care Medicine|2005|479
Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guidelines: Lymphangioleiomyomatosis Diagnosis and Management
|American Journal of Respiratory and Critical Care Medicine|2016|366
Molecules in the ARF Orbit
|Journal of Biological Chemistry|1998|343
Lymphangioleiomyomatosis Diagnosis and Management: High-Resolution Chest Computed Tomography, Transbronchial Lung Biopsy, and Pleural Disease Management. An Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2017|255